PBTK Modeling Demonstrates Contribution of Dermal and Inhalation Exposure Components to End-Exhaled Breath Concentrations of Naphthalene

Background Dermal and inhalation exposure to jet propulsion fuel 8 (JP-8) have been measured in a few occupational exposure studies. However, a quantitative understanding of the relationship between external exposures and end-exhaled air concentrations has not been described for occupational and environmental exposure scenarios. Objective Our goal was to construct a physiologically based toxicokinetic (PBTK) model that quantitatively describes the relative contribution of dermal and inhalation exposures to the end-exhaled air concentrations of naphthalene among U.S. Air Force personnel. Methods The PBTK model comprised five compartments representing the stratum corneum, viable epidermis, blood, fat, and other tissues. The parameters were optimized using exclusively human exposure and biological monitoring data. Results The optimized values of parameters for naphthalene were a) permeability coefficient for the stratum corneum 6.8 × 10−5 cm/hr, b) permeability coefficient for the viable epidermis 3.0 × 10−3 cm/hr, c) fat:blood partition coefficient 25.6, and d) other tissue:blood partition coefficient 5.2. The skin permeability coefficient was comparable to the values estimated from in vitro studies. Based on simulations of workers’ exposures to JP-8 during aircraft fuel-cell maintenance operations, the median relative contribution of dermal exposure to the end-exhaled breath concentration of naphthalene was 4% (10th percentile 1% and 90th percentile 11%). Conclusions PBTK modeling allowed contributions of the end-exhaled air concentration of naphthalene to be partitioned between dermal and inhalation routes of exposure. Further study of inter- and intraindividual variations in exposure assessment is required to better characterize the toxicokinetic behavior of JP-8 components after occupational and/or environmental exposures.

[1]  M L Shuler,et al.  Use of In Vitro Data for Construction of a Physiologically Based Pharmacokinetic Model for Naphthalene in Rats and Mice To Probe Species Differences , 1999, Biotechnology progress.

[2]  Peter P. Egeghy,et al.  Dermal Exposure to Jet Fuel JP-8 Significantly Contributes to the Production of Urinary Naphthols in Fuel-Cell Maintenance Workers , 2005, Environmental health perspectives.

[3]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[4]  Kannan Krishnan,et al.  Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. , 2003, Toxicology and applied pharmacology.

[5]  Roger Gibson,et al.  Urinary biomarkers of exposure to jet fuel (JP-8). , 2003, Environmental health perspectives.

[6]  G. Schwartz,et al.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.

[7]  M. Andersen,et al.  Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  J W Fisher,et al.  Development of a Physiologically Based Pharmacokinetic Model for Decane, a Constituent of Jet Propellent-8 , 2004, Inhalation toxicology.

[9]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[10]  P. Williams,et al.  A biophysically based dermatopharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agents. I. Theory. , 1995, Journal of pharmaceutical sciences.

[11]  R. A. McGill,et al.  Solubility properties in polymers and biological media. II. A new method for the characterisation of the adsorption of gases and vapours on solids. , 1987, Journal of chromatography.

[12]  Melvin E Andersen,et al.  A dermatotoxicokinetic model of human exposures to jet fuel. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  R. Taft,et al.  Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of nonelectrolytes in biological tissues and fluids. , 1985, Journal of medicinal chemistry.

[14]  A. Bunge,et al.  Pharmacokinetic models of dermal absorption. , 2001, Journal of pharmaceutical sciences.

[15]  H. Haussmann,et al.  Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  Sanford D Zelnick,et al.  Personal exposure to JP-8 jet fuel vapors and exhaust at air force bases. , 2000, Environmental health perspectives.

[17]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[18]  R. Guy,et al.  Structure-permeability relationships in percutaneous penetration. , 1992, Journal of pharmaceutical sciences.

[19]  V. Fiserova-Bergerova,et al.  Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. , 1984, Drug metabolism reviews.

[20]  T. Mills Predicting Body Fat Using Data on the BMI , 2005 .

[21]  A. Leo,et al.  The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. , 1995, Toxicology letters.

[22]  M. Boeniger,et al.  Methods for Assessing Risks of Dermal Exposures in the Workplace , 2002, Critical reviews in toxicology.

[23]  S. Rappaport,et al.  Environmental and biological monitoring of benzene during self-service automobile refueling. , 2000, Environmental health perspectives.

[24]  R. Taft,et al.  SOLUBILITY PROPERTIES IN POLYMERS AND BIOLOGICAL MEDIA. 2. THE CORRELATION AND PREDICTION OF THE SOLUBILITIES OF NONELECTROLYTES IN BIOLOGICAL TISSUES AND FLUIDS , 1985 .

[25]  M E Andersen,et al.  Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. , 1989, Toxicology and applied pharmacology.

[26]  H J Clewell,et al.  Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk. , 1996, Toxicology.

[27]  Wade H. Weisman,et al.  Assessment of skin absorption and penetration of JP-8 jet fuel and its components. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Melvin E Andersen,et al.  Dermal absorption and penetration of jet fuel components in humans. , 2006, Toxicology letters.

[29]  Leena A Nylander-French,et al.  Dermal exposure to jet fuel (JP-8) in US Air Force personnel. , 2005, The Annals of occupational hygiene.

[30]  Shao-Kuang Chang,et al.  Dermatotoxicokinetic Modeling of p-Nitrophenol and Its Conjugation Metabolite in Swine following Topical and Intravenous Administration , 2000 .

[31]  D. Levitt Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference , 2004, BMC clinical pharmacology.

[32]  S M Rappaport,et al.  Benzene and naphthalene in air and breath as indicators of exposure to jet fuel , 2003, Occupational and environmental medicine.

[33]  M C Kohn,et al.  A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice. , 2001, Toxicology and applied pharmacology.